WeightPump: Lifestyle Intervention in Type 2 Diabetes

Sponsor
Icadom (Industry)
Overall Status
Completed
CT.gov ID
NCT02791295
Collaborator
AGIR à Dom (Other)
54
6
2
53.4
9
0.2

Study Details

Study Description

Brief Summary

The purpose of the study is to determine whether a personalized lifestyle intervention focused on diet and physical activity reinforcement is effective in avoiding weight gain in the first months following initiation of subcutaneous insulin pump therapy in type-2 diabetic patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Diet and physical activity program
N/A

Detailed Description

Patients with type 2 diabetes using insulin pump therapy are gaining weight within the first months of treatment. This weight gain could counterbalance the metabolic benefice of insulin pump treatment in improving glycemic control and could lead to treatment dropout. Lifestyle intervention aiming at improving physical activity and diet in type 2 diabetes is known to brought body weight reduction and cardiometabolic improvement.

The investigator hypothesized that an intensive, home-based, 6-months diet and physical activity program could prevent the body weight gain associated with insulin pump treatment initiation. The investigator will randomize patients with type 2 diabetes into a "lifestyle intervention" arm or a "usual care" control arm at the time of insulin pump treatment initiation. The primary objective will evaluate body weight change at 6 months after insulin pump treatment initiation. The secondary objectives will evaluate change in glycemic control (HbA1c) and body composition at 6 months. In addition, the retention effect will be assessed on body weight change one year after insulin pump treatment initiation, 6 months after the end of the lifestyle intervention.

Study Design

Study Type:
Interventional
Actual Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Diet and Physical Activity Lifestyle Intervention to Prevent Body Weight Gain in Patients With Type 2 Diabetes Starting Insulin Pump Treatment: a Randomized Controlled Trial
Actual Study Start Date :
Oct 4, 2016
Actual Primary Completion Date :
Jan 19, 2021
Actual Study Completion Date :
Mar 17, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Diet and physical activity program

Diet and physical activity program with individual coaching

Other: Diet and physical activity program
A personalized intervention focused on improving diet and increasing physical activity will be implemented at-home with a monthly support by a registered dietician and physical activity educator during 6 months

No Intervention: control

standard care

Outcome Measures

Primary Outcome Measures

  1. Weight change [6 months]

    The difference in body weight changes between the two groups over a six-month period following initiation of insulin pump treatment.

Secondary Outcome Measures

  1. Glycemic control [6 months]

    The difference in HbA1c changes between the two groups after 6-months of insulin pump treatment initiation.

  2. Body composition [6 months]

    The difference between the two groups in distribution of fat mass and lean mass between the first visit and 6 months after initiation of insulin pump treatment.

  3. Diabetes Treatment Satisfaction [6 months]

    The difference between the two groups of scores of the Diabetes Treatment Satisfaction Questionnaire between the first visit and 6 months after initiation of insulin pump treatment.

  4. Intermediate weight change [3 months]

    The difference in weight changes between the two groups after 3-months of insulin pump treatment initiation.

  5. Retention of weight change [1 year]

    The difference in weight changes between the two groups at 12-months of insulin pump treatment initiation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult Type 2 diabetic patients with indication of initiation of insulin pump therapy.

  • Patients addressed for the insulin pump follow-up to the home care provider supporting the study.

  • Public health care security affiliation.

Exclusion Criteria:
  • Breastfeeding or pregnant woman.

  • Not willing to participate as assessed by the investigator.

  • Patient engaged in another clinical trial with exclusion criteria for other protocol.

  • Patients unable to ride a training bike.

  • Unavailable in the next 6 months.

  • Patient without a medical certificate done in the last 12 months by a cardiologist attesting the ability to participate in a physical activity reinforcement program.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Annecy-Genevois Hospital Annecy France 74370
2 Pierre Oudot Hospital Bourgoin-Jallieu France 38302
3 Métropole Savoie Hospital Chambéry France 73000
4 Alpes Léman Hospital Contamine-sur-Arve France 74130
5 Grenoble University Hospital Grenoble France 38043
6 Marseille European Hospital Marseille France 13003

Sponsors and Collaborators

  • Icadom
  • AGIR à Dom

Investigators

  • Principal Investigator: Anne-Laure Borel, MD PhD, University Hospital, Grenoble

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Icadom
ClinicalTrials.gov Identifier:
NCT02791295
Other Study ID Numbers:
  • 2016-A00481-50
First Posted:
Jun 6, 2016
Last Update Posted:
Mar 19, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Icadom
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 19, 2021